CO5540382A2 - UNA COMBINACION FARMACEUTICA QUE COMPRENDE UNO CUALQUIERA DE ACIDO (S)-2-ETOXI-3-(4-(2-(4-METANOSULFONIL OXIFENIL) ETOXI) FENIL) PROPANOICO O ACIDO 3-(4-(2-(4-TERTBUTOXI CARBONIL AMINOFENIL)ETOXI)FENIL)-(s)-2-ETOXI PROPANOICO Y UNA SULFONILUREA - Google Patents
UNA COMBINACION FARMACEUTICA QUE COMPRENDE UNO CUALQUIERA DE ACIDO (S)-2-ETOXI-3-(4-(2-(4-METANOSULFONIL OXIFENIL) ETOXI) FENIL) PROPANOICO O ACIDO 3-(4-(2-(4-TERTBUTOXI CARBONIL AMINOFENIL)ETOXI)FENIL)-(s)-2-ETOXI PROPANOICO Y UNA SULFONILUREAInfo
- Publication number
- CO5540382A2 CO5540382A2 CO03112113A CO03112113A CO5540382A2 CO 5540382 A2 CO5540382 A2 CO 5540382A2 CO 03112113 A CO03112113 A CO 03112113A CO 03112113 A CO03112113 A CO 03112113A CO 5540382 A2 CO5540382 A2 CO 5540382A2
- Authority
- CO
- Colombia
- Prior art keywords
- etoxi
- phenyl
- ethoxy
- propanoic
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Una combinación farmacéutica que comprende uno cualquiera de ácido (S)-2-etoxi-3-[4-(2-{4-metanosulfoniloxifenil}etoxi)fenil] propanoico o ácido 3-{4-[2-(4-tert-butoxicarbonilaminofenil)etoxi]fenil}-(S)-2-etoxi propanoico, o una sal farmacéuticamente aceptable de los mismos y solvatos cualesquiera de uno cualquiera de los mismos y una sulfonilurea.7.- Una preparación combinada que comprende: (1) una formulación farmacéutica que incluye uno cualquiera de ácido (S)-2-etoxi-3-[4-(2-{4-metano-sulfoniloxifenil}etoxi)fenil] propanoico o 3- { 4-[2-( 4-tert-butoxicarbonil-aminofenil)-etoxi]fenil}-(S)-2-etoxi propanoico, o una sal farmacéuticamente aceptable de los mismos y una sulfonilurea, en mezcla con un coadyuvante, diluyente o portador farmacéuticamente aceptables; y (2) un kit de partes que comprende componentes:(a) una formulación farmacéutica que incluye uno cualquiera de ácido (S)-2-etoxi-3-[4-(2-{4-metanosulfoniloxifenil}etoxi)fenil] propanoico o 3-{4-[2-(4-tert-butoxicarbonil-aminofenil)-etoxi]fenil} -(S)-2-etoxi propanoico, o una sal farmacéuticamente aceptable de los mismos en mezcla con un coadyuvante, diluyente o portador farmacéuticamente aceptables; y(b) una formulación farmacéutica que incluye una sulfonilurea en mezcla con un coadyuvante, diluyente o portador farmacéuticamente aceptables, los cuales componentes (a) y (b) se proveen cada uno en una forma que es apropiada para administración en conjunción con el otro.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101982A SE0101982D0 (sv) | 2001-06-01 | 2001-06-01 | Pharmaceutical combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5540382A2 true CO5540382A2 (es) | 2005-07-29 |
Family
ID=20284364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO03112113A CO5540382A2 (es) | 2001-06-01 | 2003-12-23 | UNA COMBINACION FARMACEUTICA QUE COMPRENDE UNO CUALQUIERA DE ACIDO (S)-2-ETOXI-3-(4-(2-(4-METANOSULFONIL OXIFENIL) ETOXI) FENIL) PROPANOICO O ACIDO 3-(4-(2-(4-TERTBUTOXI CARBONIL AMINOFENIL)ETOXI)FENIL)-(s)-2-ETOXI PROPANOICO Y UNA SULFONILUREA |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040157927A1 (es) |
| EP (1) | EP1399166A1 (es) |
| JP (1) | JP2004532891A (es) |
| KR (1) | KR20040007624A (es) |
| CN (1) | CN1250226C (es) |
| BR (1) | BR0210127A (es) |
| CA (1) | CA2448763A1 (es) |
| CO (1) | CO5540382A2 (es) |
| CZ (1) | CZ20033235A3 (es) |
| EE (1) | EE200300583A (es) |
| HU (1) | HUP0401613A3 (es) |
| IL (1) | IL159035A0 (es) |
| IS (1) | IS7057A (es) |
| MX (1) | MXPA03011010A (es) |
| NO (1) | NO20035235D0 (es) |
| PL (1) | PL367890A1 (es) |
| RU (1) | RU2003136157A (es) |
| SE (1) | SE0101982D0 (es) |
| SK (1) | SK14722003A3 (es) |
| WO (1) | WO2002100413A1 (es) |
| ZA (1) | ZA200309263B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008019169A (ja) * | 2004-10-25 | 2008-01-31 | Osaka Univ | 新規ｐｐａｒ調節剤およびそのスクリーニング方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| US5783556A (en) * | 1996-08-13 | 1998-07-21 | Genentech, Inc. | Formulated insulin-containing composition |
| US6552055B2 (en) * | 1996-12-11 | 2003-04-22 | Dana-Farber Cancer Institute | Methods and pharmaceutical compositions for inhibiting tumor cell growth |
| US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
-
2001
- 2001-06-01 SE SE0101982A patent/SE0101982D0/xx unknown
-
2002
- 2002-05-30 PL PL02367890A patent/PL367890A1/xx not_active Application Discontinuation
- 2002-05-30 EP EP02736370A patent/EP1399166A1/en not_active Withdrawn
- 2002-05-30 KR KR10-2003-7015644A patent/KR20040007624A/ko not_active Application Discontinuation
- 2002-05-30 EE EEP200300583A patent/EE200300583A/xx unknown
- 2002-05-30 CA CA002448763A patent/CA2448763A1/en not_active Abandoned
- 2002-05-30 BR BR0210127-0A patent/BR0210127A/pt not_active IP Right Cessation
- 2002-05-30 IL IL15903502A patent/IL159035A0/xx unknown
- 2002-05-30 MX MXPA03011010A patent/MXPA03011010A/es unknown
- 2002-05-30 RU RU2003136157/15A patent/RU2003136157A/ru not_active Application Discontinuation
- 2002-05-30 HU HU0401613A patent/HUP0401613A3/hu unknown
- 2002-05-30 WO PCT/SE2002/001036 patent/WO2002100413A1/en not_active Application Discontinuation
- 2002-05-30 SK SK1472-2003A patent/SK14722003A3/sk not_active Application Discontinuation
- 2002-05-30 CZ CZ20033235A patent/CZ20033235A3/cs unknown
- 2002-05-30 US US10/479,205 patent/US20040157927A1/en not_active Abandoned
- 2002-05-30 CN CNB028149882A patent/CN1250226C/zh not_active Expired - Fee Related
- 2002-05-30 JP JP2003503234A patent/JP2004532891A/ja not_active Withdrawn
-
2003
- 2003-11-25 NO NO20035235A patent/NO20035235D0/no not_active Application Discontinuation
- 2003-11-27 ZA ZA200309263A patent/ZA200309263B/en unknown
- 2003-11-28 IS IS7057A patent/IS7057A/is unknown
- 2003-12-23 CO CO03112113A patent/CO5540382A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200309263B (en) | 2005-03-11 |
| RU2003136157A (ru) | 2005-05-20 |
| US20040157927A1 (en) | 2004-08-12 |
| CZ20033235A3 (cs) | 2004-12-15 |
| BR0210127A (pt) | 2004-06-08 |
| CN1250226C (zh) | 2006-04-12 |
| SE0101982D0 (sv) | 2001-06-01 |
| EE200300583A (et) | 2004-02-16 |
| IS7057A (is) | 2003-11-28 |
| PL367890A1 (en) | 2005-03-07 |
| EP1399166A1 (en) | 2004-03-24 |
| HUP0401613A2 (hu) | 2004-11-29 |
| IL159035A0 (en) | 2004-05-12 |
| WO2002100413A1 (en) | 2002-12-19 |
| CN1537008A (zh) | 2004-10-13 |
| HUP0401613A3 (en) | 2007-11-28 |
| SK14722003A3 (sk) | 2004-08-03 |
| NO20035235D0 (no) | 2003-11-25 |
| MXPA03011010A (es) | 2004-02-27 |
| JP2004532891A (ja) | 2004-10-28 |
| KR20040007624A (ko) | 2004-01-24 |
| CA2448763A1 (en) | 2002-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2525418T3 (es) | Composiciones farmacéuticas que comprenden cilostazol y un inhibidor de la recaptación de adenosina | |
| AR012732A1 (es) | Derivados de fenilquinolinas, procedimientos para su preparacion, composiciones farmaceuticas, y su uso para la fabricacion de medicamentos | |
| BR9910913A (pt) | Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com resistência a insulina | |
| AR010843A1 (es) | Compuestos agonistas de prostaglandinas procedimiento de uso y composiciones | |
| AR047823A1 (es) | Derivados de 1,2,3,4-tetrahidroisoquinolina sustituida | |
| AR040474A1 (es) | Derivados de tiofenolglicosido, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| BR0213027A (pt) | Método para preparar compostos benzenosulfonila | |
| CO5540383A2 (es) | UNA COMBINACION FARMACEUTICA QUE COMPRENDE UNO CUALQUIERA DE ACIDO (S)-2-ETOXI-3-(4-(2-(4-METANOSULFONIL OXIFENIL) ETOXI)FENIL) PROPANOICO O ACIDO 3-(4-(2-(4-TERT-BUTOXI CARBONIL-AMINOFENIL)ETOXI)FENIL)-(s)-2-ETOXI PROPANOICO E INSULINA | |
| CO5540382A2 (es) | UNA COMBINACION FARMACEUTICA QUE COMPRENDE UNO CUALQUIERA DE ACIDO (S)-2-ETOXI-3-(4-(2-(4-METANOSULFONIL OXIFENIL) ETOXI) FENIL) PROPANOICO O ACIDO 3-(4-(2-(4-TERTBUTOXI CARBONIL AMINOFENIL)ETOXI)FENIL)-(s)-2-ETOXI PROPANOICO Y UNA SULFONILUREA | |
| BR0208275A (pt) | Composições farmacêuticas para tratamento de arteriosclerose | |
| BRPI0517550A (pt) | sistema de dispensamento de artigo absorvente | |
| AR018867A1 (es) | Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche | |
| UY27461A1 (es) | Formas pseudopolimorficas de cardevilol. | |
| AR020773A1 (es) | Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto | |
| AR046719A1 (es) | Sales de benzazepina y composiciones farmacéuticas que las contienen. | |
| BRPI0418226A (pt) | preparação de cloridrato r-5-(2-(2-(2-etoxifenoxietilamino) propil-2-metoxibenzenossulfonamida de alta pureza quìmica | |
| AR044826A1 (es) | Sales derivadas del acido propionico,y su uso medicinal | |
| HUP0303481A2 (hu) | 3,7-Diaza-biciklo-[3,3,1] vegyületeket tartalmazó készítmények mint anti-aritmiás szerek | |
| IS7058A (is) | Lyfjablanda sem annaðhvort felur í sér (S)-2-etoxý-3-[4-(2-{4-metansúlfónýloxýfenýl} etoxý)fenýl] própansýru eða 3-{4-[2-(4-tert-bútoxýkarbónýlamínófenýl)etoxý]fenýl}-(S)-2-etoxýprópansýru og bígúaníðlyf | |
| AR039184A1 (es) | Supositorios de meloxicam | |
| UY28367A1 (es) | Agentes terapéuticos | |
| AR037712A1 (es) | Combinacion farmaceutica | |
| ATE350038T1 (de) | Pharmazeutische zubereitungen enthaltend nanopartikel von 2-(4-ethoxy-phenyl)-3-(4- methansulphonyl-phenyl)-pyrazolo 1,5-böpyridazi | |
| SE9100289L (sv) | Herbicidally active substituted sulfonyl urea derivatives and a process for the preparation thereof | |
| UY24199A1 (es) | Nuevos derivados de etanolamina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |